Core Viewpoint - The announcement details the progress of a second judicial auction of shares held by the controlling shareholder of Yuekang Pharmaceutical Group Co., Ltd, indicating that 26,500,000 shares have been auctioned off, representing 5.88% of the company's total share capital [4][5]. Group 1: Auction Details - The auction took place from July 14, 2025, to July 15, 2025, on the JD.com judicial auction platform [1]. - A total of 26,500,000 shares were auctioned, with the final transaction amounting to 486,520,200.00 yuan [2][4]. - The shares sold represent 5.88% of the company's total share capital and 14.70% of the shares held by the controlling shareholder [4][5]. Group 2: Auction Results - The auction concluded successfully, with all shares sold to two bidders: Li Chunyan and Ni Aihua, who acquired 1,250,000 shares and 1,200,000 shares respectively [2][4]. - The auction results are subject to the completion of payment and transfer procedures, with the final outcome dependent on the court's confirmation [4][5]. Group 3: Impact on Company - The auction is not expected to have a significant adverse impact on the company's management or lead to changes in the controlling shareholder [4][5]. - The new shareholders will be restricted from selling the acquired shares for six months following the auction [5].
悦康药业: 关于控股股东所持公司部分股份被第二次司法拍卖的进展公告